Financhill
Back

4D Molecular Therapeutics Quote, Financials, Valuation and Earnings

Better Than Oil Stocks

CLICK HERE TO FIND OUT MORE
Buy
51

FDMT
4D Molecular Therapeutics

Last Price:
6.90
Seasonality Move:
19.19%

7 Day Trial

ALL ACCESS PASS

$ 7

Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!

Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)

4D Molecular Therapeutics Price Quote

$6.90
-0.34 (-4.7%)
(Updated: December 11, 2024 at 5:55 PM ET)

4D Molecular Therapeutics Key Stats

Buy
51
4D Molecular Therapeutics (FDMT) is a Buy

Day range:
$6.99 - $7.33
52-week range:
$6.77 - $36.25
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
21,611.02
P/B ratio:
0.61%

Volume:
461K
Avg. volume:
770.9K
1-year change:
-51.54%
Market cap:
$334.7M
Revenue:
$20.7M
EPS:
$-2.85

How Much Does 4D Molecular Therapeutics Make?

Is 4D Molecular Therapeutics Growing As A Company?

4D Molecular Therapeutics Stock Price Performance

What Is 4D Molecular Therapeutics 52-Week High & Low?

4D Molecular Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy 4D Molecular Therapeutics?

Is 4D Molecular Therapeutics Cash Flow Positive?

  • What Is FDMT Cash Flow From Operations?
    Cash flow from operations (TTM) is -$113.4M
  • What Is 4D Molecular Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $341.4M
  • What Is 4D Molecular Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$316.2M

4D Molecular Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    FDMT return on invested capital is -30.15%
  • What Is 4D Molecular Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -28.07%
  • What Is FDMT Return On Equity?
    ROE is a measure of profitability and is -30.15%

4D Molecular Therapeutics Earnings Date & Stock Price

4D Molecular Therapeutics Competitors

4D Molecular Therapeutics Dividend Yield

4D Molecular Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -12.16%
Revenue: -99.99% -99.5%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 1
Sell Recommendations: 1
Price Target: 45.64
Upside from Last Price: 530.34%

Major Shareholders

  • How many FDMT shares are owned by institutional investors?
    92.5M FDMT shares are owned by institutional investors
  • How many FDMT shares are owned by insiders?
    2M FDMT shares are owned by insiders